# PT-141 Vial

- Link: https://palmbeach-vitality.store/es/product/pt-141-vial/
- Published: 2026-07-29T19:47:52-04:00
- Author: Salvatore Johnson

**PT-141 10 mL Vial**

**The Science, Simplified:** PT-141 (bremelanotide) is a synthetic cyclic heptapeptide
analog of alpha-MSH studied as a melanocortin receptor agonist research tool, particularly
at MC3R and MC4R in experimental models.

**Product Specifications – PT-141 10 mL Vial (20 mg)**

 * Total PT-141: 20 mg
 * Volume: 10 mL vial
 * Concentration: 2 mg/mL
 * Purity: Research-grade, third-party tested (COA available)
 * Format: Ready-to-use liquid vial

**Key Research Focus:** Used in laboratory melanocortin receptor pharmacology assays
examining central MC3R/MC4R signaling pathways under RUO conditions.

**Physical Form & Solubility:**

 * Appearance: Clear to slightly opalescent liquid
 * Solubility: Already in aqueous solution (acetate salt form for optimal solubility
   and stability). Highly soluble; no reconstitution required.

**Stability & Handling Notes:**

 * Refrigerated at 36-46°F. Practical shelf life is **16-20 weeks** when protected
   from light and handled with aseptic technique.
 * Do not freeze. Avoid prolonged room-temperature exposure.
 * Discard after 20 weeks or if the solution becomes cloudy, discolored, or shows
   particulate matter.
 * Protect from light and moisture at all times.
 * For **lyophilized** orders please contact us (minimum order required)
   [https://www.palmbeach-vitality.com](https://www.palmbeach-vitality.com)

PT-141 20 mg / 10 mL (2 mg/mL) research vial from Palm Beach Vitality. Third-party
tested with COA. Laboratory research use only.

**How Labs Use This Format:** Investigators pipette at 2 mg/mL from this ready-to-
use liquid vial for melanocortin receptor pathway work. Pen formats may be available
in the peptide pens category if listed live.

**Documentation Trail:** Third-party testing and lot-matched COA from Palm Beach
Vitality support laboratory procurement records. Cold-pack shipping on qualifying
orders.
